
NephLong
Xonimide ODT
Details
50 mg
Generic Name: Zonisamide
Description:
Xonimide ODT is an orally disintegrating tablet containing zonisamide, an anticonvulsant medication. Zonisamide belongs to the class of sulfonamide anticonvulsants and is used primarily to treat epilepsy by reducing the frequency of seizures. The ODT (orally disintegrating tablet) formulation allows the tablet to rapidly dissolve in the mouth without the need for water, providing ease of administration especially for patients who have difficulty swallowing conventional tablets.
Mechanism of Action:
Zonisamide works by stabilizing neuronal membranes and suppressing neuronal hypersynchronization through multiple mechanisms, including blocking voltage-dependent sodium channels and T-type calcium channels. This reduces abnormal electrical activity in the brain that leads to seizures.
Indications:
-
Adjunctive therapy for partial seizures in patients with epilepsy
-
Monotherapy or adjunct therapy for other seizure types as determined by the physician
Dosage Form:
-
Dispersible orally disintegrating tablets (ODT) for easy administration
Benefits:
-
Rapid disintegration in the mouth
-
Convenient for patients with swallowing difficulties
-
Effective seizure control
Common Side Effects:
-
Drowsiness
-
Dizziness
-
Loss of appetite
-
Nausea
-
Headache
Precautions:
-
Patients with sulfonamide allergy should avoid this medication
-
Regular monitoring by healthcare provider recommended
-
Use caution in patients with kidney or liver impairment
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.